The Trainee Oral Symposium will take place on Thursday, March 21, 2019. Trainees are encouraged to submit oral abstracts via this registration form. Oral abstracts are due by Friday, February 1st. Applicants will be notified within a week of the abstract deadline. This event will include trainee oral presentations, a career panel and a keynote.
Light refreshments will be served.
Registration requested, but not required to attend.
12:25pm Trainee oral presentations (full schedule to be posted)
2:40pm Career panel
- Ericka Hayes, MD, Associate Professor, Department of Pediatrics, Division of Infectious Diseases, Washington University
- Sebla Kutluay, PhD, Assistant Professor, Department of Molecular Microbiology, Washington University
- John Santelli, MD, MPH, FAAP, FASHA, Professor, Population and Family Health and Pediatrics, Mailman School of Public Health and College of Physicians and Surgeons, Columbia University
- Robert Schooley, MD
3:45pm Keynote presentation: Robert Schooley, MD
Ending AIDS: No HIV Vaccine – No Problem
- HIV vaccine research has provided major insights into the immunobiology of HIV but the time has passed to make plans about ending the HIV epidemic based on the assumption that an effective HIV vaccine will be developed in the foreseeable future.
- With a combination of antiretroviral therapeutics, apolitical public health interventions and an easily accessible health care system, AIDS can be ended in the US and abroad.
4:30pm Networking reception (light refreshments will be provided)
Robert Schooley, MD
Professor of Medicine, Division of Infectious Diseases, Vice Chair, Department of Medicine, Senior Director, International Initiatives, University of California, San Diego
Dr. Schooley began his research career studying the immunopathogenesis of herpesvirus infections in immunocompromised patients, but shifted his focus to AIDS in 1981 when the first cases of this syndrome began to appear in Boston. His research group was among the first to delineate the humoral and cellular immune responses to HIV infection. Over the next 15 years he became increasingly involved in the discovery and development of antiretroviral chemotherapeutic agents including reverse transcriptase inhibitors, protease inhibitors and entry inhibitors. He was recruited to the University of Colorado Health Sciences Center in 1990 to serve as Head of the Division of Infectious Diseases. While at Colorado, he was elected to serve as Chair of the NIAID’s AIDS Clinical Trials Group (ACTG) which he headed from 1995 – 2002. During his tenure as Group Chair, the ACTG expanded to include research sites in Latin America, the Caribbean, South Asia and Africa and is now the largest and most productive multinational clinical and translational research organization focusing on the pathogenesis and therapy of HIV and its complications. Currently, Dr. Schooley’s personal research interests include HCV, influenza and HIV pathogenesis, and therapy and infections that cause morbidity and mortality in resource limited settings.
PARKING & DIRECTIONS
Click here for driving and public transit directions.
Upon arriving, please utilize levels 6-7 of the Metro Parking Garage located at the corner of Taylor Avenue and Children’s Place. The address is 4560 Children’s Place, St. Louis, MO 63110. Please note, the Metro Parking Garage only accepts cash.
Event Sponsors: Global Health Center at the Institute for Public Health